The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 17, 2019

Filed:

Apr. 27, 2017
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Mitsuko L. Yamamoto, Alameda, CA (US);

Robert H. Schiestl, Encino, CA (US);

Ramune Reliene, Delmar, NY (US);

James Borneman, Riverside, CA (US);

Laura L. Presley, Santa Maria, CA (US);

Jonathan Braun, Tarzana, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/747 (2015.01); A61K 9/68 (2006.01); A23C 9/158 (2006.01); A23G 1/42 (2006.01); A61K 45/06 (2006.01); A61K 9/14 (2006.01); A61K 9/08 (2006.01); A23K 20/10 (2016.01); A61K 8/99 (2017.01); A23G 4/12 (2006.01); A61Q 11/00 (2006.01); A61K 35/76 (2015.01); A61K 35/00 (2006.01); A23C 9/123 (2006.01); A23L 2/52 (2006.01); A61K 9/00 (2006.01); A23K 10/18 (2016.01); A23L 33/135 (2016.01);
U.S. Cl.
CPC ...
A61K 35/747 (2013.01); A23C 9/123 (2013.01); A23C 9/1232 (2013.01); A23C 9/1585 (2013.01); A23G 1/42 (2013.01); A23G 4/12 (2013.01); A23K 10/18 (2016.05); A23K 20/10 (2016.05); A23L 2/52 (2013.01); A23L 33/135 (2016.08); A61K 8/99 (2013.01); A61K 9/0058 (2013.01); A61K 9/0095 (2013.01); A61K 9/14 (2013.01); A61K 35/76 (2013.01); A61K 45/06 (2013.01); A61Q 11/00 (2013.01); A23V 2002/00 (2013.01); A23Y 2220/43 (2013.01); A61K 9/08 (2013.01); A61K 2035/11 (2013.01); A61K 2800/85 (2013.01); A61K 2800/92 (2013.01); Y02A 50/475 (2018.01); Y02A 50/481 (2018.01);
Abstract

Inoculation of ATM-deficient mice with probiotic microorganisms, such as, changed immune parameters, decreased a marker of DNA damage and increased the lifespan of the mice. Compositions and methods described herein are useful for the treatment and prevention of Ataxia telangiectasia and other cancer-prone disease, such as p53 deficiency-associated cancers. Compositions and methods of the present invention are also useful for treating and preventing radiation-induced toxicity to normal tissue in a subject being exposed to radiation. Compositions and methods of the invention can increase lifespans in a simple, non-invasive manner.


Find Patent Forward Citations

Loading…